IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.

Item Statistics

Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin

RepositoryUniversity of Melbourne [Minerva Access]
URLhttp://hdl.handle.net/11343/219162
Author(s)orcid:0000-0002-0278-4801; orcid:0000-0002-8152-2120; orcid:0000-0001-5049-8861; orcid:0000-0002-5159-3438; Bennett, IE; Field, KM; Hovens, CM; Moffat, BA; Rosenthal, MA; Drummond, K; Kaye, AH; Morokoff, AP
Item typeArticle
JournalJournal of Neuro-Oncology, Print_ISSN:0167-594X, Online_ISSN:1573-7373
DOIhttps://doi.org/10.1007/s11060-016-2300-0

Usage Date Range

Note: Daily statistics are only available for the last six weeks.

     

Reporting Period Total 2021-12-04 2021-12-05 2021-12-06 2021-12-07 2021-12-08 2021-12-09 2021-12-10 2021-12-11 2021-12-12 2021-12-13 2021-12-14 2021-12-15 2021-12-16 2021-12-17 2021-12-18 2021-12-19 2021-12-20 2021-12-21 2021-12-22 2021-12-23 2021-12-24 2021-12-25
4 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1
Jisc logo Cranfield logo CAVAL logo